A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Lahat, Hadas, Pras, Elon, Olender, Tsviya, Avidan, Nili, Ben-Asher, Edna, Man, Orna, Levy-Nissenbaum, Etgar, Khoury, Asad +4 more·2001·The American Journal of Human Genetics
DOI 10.1086/324565

Cited by (653)

Items 301–400 of 653

  1. Genetics of Long QT, Brugada, and Other Channelopathies
    Silvia Giuliana Priori, Ilaria Rivolta, Carlo Napolitano · 2004 · Elsevier eBooks
  2. Abnormal Ca2+ homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification
    Yanmin Zhang, Gareth D. K. Matthews, Ming Lei, Christopher L.-H. Huang · 2013 · Frontiers in Physiology
  3. Sudden cardiac arrest: Limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes
    Sudarshan Srivats, Fawzi Zghyer, Zaid Shahrori, Christine Albert, S. Al-Khatib, S. Chugh, Susan P. Etheridge, Zachary D. Goldberger, Rakesh Gopinathannair, D. Lakkireddy et al. · 2025 · Progress in cardiovascular diseases
  4. Role of pharmacotherapy in cardiac ion channelopathies
    Nabil El‐Sherif, Mohamed Boutjdir · 2015 · Pharmacology & Therapeutics
  5. The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia
    Krystien V.V. Lieve, Arthur A.M. Wilde, Christian van der Werf · 2016 · Arrhythmia & Electrophysiology Review
  6. Mechanisms underlying pathological Ca2+ handling in diseases of the heart
    Satadru K. Lahiri, Yuriana Aguilar-Sánchez, Xander H.T. Wehrens · 2021 · Pflügers Archiv - European Journal of Physiology
  7. Functional importance of polymerization and localization of calsequestrin inC. elegans
    Jeong Hoon Cho, K. M. Ko, Gunasekaran Singaruvelu, Wonhae Lee, Gil Bu Kang, Seong‐Hwan Rho, Byung-Jae Park, Jae-Ran Yu, Hiroaki Kagawa, Soo Hyun Eom et al. · 2007 · Journal of Cell Science
  8. Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population
    Estefanía Martinez-Barrios, Sergi César, Jose Carlos Cruzalegui, Clara Hernandez, Elena Arbelo, Victoria Fiol, Josép Brugada, Ramón Brugada, Óscar Campuzano, Georgia Sarquella‐Brugada · 2022 · Biomedicines
  9. Latent Causes of Sudden Cardiac Arrest
    Andrew David Krahn, Jacob Tfelt‐Hansen, Rafik Tadros, Christian Steinberg, Christopher Semsarian, Hui‐Chen Han · 2022 · JACC. Clinical electrophysiology
  10. Genomics, heart failure and sudden cardiac death
    Dawood Darbar · 2008 · Heart Failure Reviews
  11. Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population
    Annukka M. Lahtinen, Aki Samuli Havulinna, Peter A. Noseworthy, Antti Jula, Pekka J. Karhunen, Markus Perola, Christopher Newton‐Cheh, Veikko V Salomaa, KIMMO K. KONTULA · 2013 · Annals of Medicine
  12. Evidence for a functional role of calsequestrin 2 in mouse atrium
    Ulrich Gergs, Carola Fahrion, P. Bock, M. Fischer, Hartmut Wache, Steffen Hauptmann, Wilhelm Ludolf Schmitz, Joachim Neumann · 2016 · Acta Physiologica
  13. The elusive role of store depletion in the control of intracellular calcium release
    Eduardo Rı́os, Bradley S. Launikonis, Leandro O. Royer, Gustavo Brum, J. Zhou · 2006 · Journal of Muscle Research and Cell Motility
  14. Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
    Khalil Saadeh, Ibrahim T. Fazmin · 2021 · Frontiers in Cardiovascular Medicine
  15. The effect of statins on RyR and RyR-associated disease
    Mohsin Haseeb, Paul D. Thompson · 2021 · Journal of Applied Physiology
  16. Personalized medicine in cardiovascular disease: review of literature
    Ali Sheikhy, Aida Fallahzadeh, Hamid Reza Aghaei Meybodi, Mandana Hasanzad, Masih Tajdini, Kaveh Hosseini · 2021 · Journal of Diabetes & Metabolic Disorders
  17. The function and regulation of calsequestrin-2: implications in calcium-mediated arrhythmias
    Elliot T. Sibbles, Helen M. M. Waddell, Valeria Mereacre, Peter P. Jones, Michelle L. Munro · 2022 · Biophysical Reviews
  18. Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2
    Matthew J. Wleklinski, Dmytro O. Kryshtal, Kyungsoo Kim, Shan S. Parikh, Daniel J. Blackwell, Isabelle Marty, Veena R. Iyer, Björn C. Knollmann · 2022 · Circulation Research
  19. Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
    Jingshan Gao, Takeru Makiyama, Yuta Yamamoto, Takuya Kobayashi, Hisaaki Aoki, Thomas L. Maurissen, Yimin Wuriyanghai, Asami Kashiwa, Tomohiko Imamura, Takanori Aizawa et al. · 2023 · Circulation Arrhythmia and Electrophysiology
  20. The Genetic and Clinical Features of Cardiac Channelopathies
    Jason D. Roberts, Michael H. Gollob · 2010 · Future Cardiology
  21. Compound heterozygous CASQ 2 mutations and long‐term course of catecholaminergic polymorphic ventricular tachycardia
    Katherine S. Josephs, Kunjan Patel, Christopher M. Janson, Cristina Montagna, Thomas V. McDonald · 2017 · Molecular Genetics & Genomic Medicine
  22. Exploring the underlying biology of intrinsic cardiorespiratory fitness through integrative analysis of genomic variants and muscle gene expression profiling
    Sujoy Ghosh, Monalisa Hota, Xiaoran Chai, Jencee Kiranya, Palash Ghosh, Zihong He, Jonathan J. Ruiz‐Ramie, Mark A. Sarzynski, Claude Bouchard · 2019 · Journal of Applied Physiology
  23. Gender Differences in Cardiac Arrhythmias
    Eric Schulze‐Bahr, Paulus F. Kirchhof, Lars Eckardt, Jessica Bertrand, Günter Breithardt · 2005 · Herz
  24. Cardiac Calsequestrin: The New Kid on the Block in Arrhythmias
    Nagesh Chopra, Björn C. Knollmann · 2009 · Journal of Cardiovascular Electrophysiology
  25. Sudden Unexplained Death Caused by Cardiac Ryanodine Receptor (RyR2) Mutations
    Xander H.T. Wehrens, Andrew R. Marks · 2004 · Mayo Clinic Proceedings
  26. Catecholaminergic Polymorphic Ventricular Tachycardia
    Nian Liu, Carlo Napolitano, Silvia Giuliana Priori · 2008 · Springer eBooks
  27. Agonists and antagonists of the cardiac ryanodine receptor: Potential therapeutic agents?
    Angela Fay Dulhunty, Nicole A. Beard, Pierre Pouliquin, Marco Giovani Casarotto · 2006 · Pharmacology & Therapeutics
  28. Genetics of familial cardiomyopathies and arrhythmias
    Lucie Carrier, Ketty Schwartz · 2002 · Swiss Medical Weekly
  29. CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression
    Yingjie Liu, Jinhong Wei, Siobhan M. Wong King Yuen, Bo Sun, Yijun Tang, Ruiwu Wang, Filip Van Petegem, S.R. Wayne Chen · 2017 · PLoS ONE
  30. The role of luminal Ca regulation in Ca signaling refractoriness and cardiac arrhythmogenesis
    Sándor Györke, Andriy E. Belevych, Bin Liu, Igor V. Kubasov, Cynthia A. Carnes, Przemysław Radwański · 2017 · The Journal of General Physiology
  31. Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias
    Charles N Antzelevitch · 2003 · Pacing and Clinical Electrophysiology
  32. Basic and Clinical Insights in Catecholaminergic (Familial) Polymorphic Ventricular Tachycardia
    Manlio Fabio Márquez, Armando Totomoch-Serra, Angélica Rueda, Josè Everardo Avelino-Cruz, Antonio Gallegos-Cortez · 2019 · Revista de investigaci�n Cl�nica
  33. Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 Mutation
    Ronny Alcalai, Hiroko Wakimoto, Michael Arad, David Planer, Tetsuo Konno, LIBIN WANG, Jonathan G. Seidman, Christine E. Seidman, Charles I. Berul · 2010 · Journal of Cardiovascular Electrophysiology
  34. Differential protein expression in heart in UT‐B null mice with cardiac conduction defects
    Hao Yu, Yan Meng, Li‐Shun Wang, Xian Jin, Lifang Gao, Lei Zhou, Kun Ji, Yang Li, Li‐Juan Zhao, Guoqiang Chen et al. · 2009 · PROTEOMICS
  35. The electrical heart: 25 years of discovery in cardiac electrophysiology, arrhythmias and sudden death
    Jeffrey E. Saffitz, Domenico Corradi · 2015 · Cardiovascular Pathology
  36. Dantrolene
    Dan M. Roden, Björn C. Knollmann · 2014 · Circulation
  37. Polymorphism identification and cardiac gene expression analysis of the calsequestrin 2 gene in broiler chickens with sudden death syndrome
    Mehdi Basaki, Keramat Asasi, Mohammad Reza Tabandeh, Mahmoud Aminlari · 2016 · British Poultry Science
  38. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background
    Anuradha Kalyanasundaram, Serge Viatchenko‐Karpinski, Andriy E. Belevych, Véronique A. Lacombe, Hyun Seok Hwang, Björn C. Knollmann, Sándor Györke, Muthu Periasamy · 2011 · American Journal of Physiology-Heart and Circulatory Physiology
  39. Post-natal heart adaptation in a knock-in mouse model of calsequestrin 2-linked recessive catecholaminergic polymorphic ventricular tachycardia
    Giorgia Valle, Simona Boncompagni, Roberta Sacchetto, Feliciano Protasi, Pompeo Volpe D · 2013 · Experimental Cell Research
  40. Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management
    Nathalie Roux-Buisson, John Rendu, Isabelle Denjoy, Pascale Guicheney, Alice Goldenberg, Nadine David, Laurence Olivier Faivre, Olivier Barthez, Gian Antonio Danieli, Isabelle Marty et al. · 2011 · Human Mutation
  41. Risk Stratification and Management of Sudden Cardiac Death:
    Nabil El‐Sherif, Gioia Turitto · 2003 · Journal of Cardiovascular Electrophysiology
  42. LQT4 Gene: The "Missing" Ankyrin
    S. Yong · 2003 · Molecular Interventions
  43. Management of survivors of cardiac arrest — the importance of genetic investigation
    Peter J. Schwartz, Federica Dagradi · 2016 · Nature Reviews Cardiology
  44. A network-oriented perspective on cardiac calcium signaling
    Christopher H. George, Dimitris Parthimos, Nicole C. Silvester · 2012 · American Journal of Physiology-Cell Physiology
  45. Just Sinus Bradycardia or Something More Serious?
    Kelly R. Egan, J. Carter Ralphe, Larry Weinhaus, Kathleen R. Maginot · 2013 · Case Reports in Pediatrics
  46. Novel Aspects on Epilepsy
    H. Foyaca-Sibat · 2011 · InTech eBooks
  47. The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies
    Enya R. Dewars, Andrew Paul Landstrom · 2024 · Annual Review of Medicine
  48. Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Atara Novak, Avraham Lorber, Joseph Itskovitz‐Eldor, Ofer Binah · 2012 · Rambam Maimonides Medical Journal
  49. Use of genetic testing to identify sudden cardiac death syndromes
    Matteo Vatta, Katherine G. Spoonamore · 2015 · Trends in Cardiovascular Medicine
  50. Integration of Genetics into a Systems Model of Electrocardiographic Traits Using HumanCVD BeadChip
    Tom R. Gaunt, Sonia H Shah, Christopher P. Nelson, Fotios Drenos, Peter S. Braund, Ismail Adeniran, Lasse Folkersen, Debbie A. Lawlor, Juan Pablo Casas, Antoinette Amuzu et al. · 2012 · Circulation Cardiovascular Genetics
  51. Protein expression profiles in murine ventricles modeling catecholaminergic polymorphic ventricular tachycardia: effects of genotype and sex
    Khalil Saadeh, Zakaria Achercouk, Ibrahim T. Fazmin, Nakulan Nantha Kumar, Samantha C. Salvage, Charlotte E. Edling, Christopher L.-H. Huang, Kamalan Jeevaratnam · 2020 · Annals of the New York Academy of Sciences
  52. The genetic basis of sudden death in young people – Cardiac and non-cardiac
    Fan Li, Ping Yin, Zuojun Xu · 2021 · Gene
  53. Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine
    Emiliano J. Sanchez, Robert P. Hayes, John Barr, Kevin M. Lewis, Brian N. Webb, Arun Kumar Subramanian, Mark S. Nissen, Jeffrey P. Jones, Eric A. Shelden, Barbara A. Sorg et al. · 2013 · Drug and Alcohol Dependence
  54. Sudden cardiac death among competitive adult athletes: a review
    Andrew Pugh, John P. Bourke, Vijay Kunadian · 2012 · Postgraduate Medical Journal
  55. A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia
    Claudia Di Blasi, Serena Sansanelli, Alessandra Ruggieri, Manuela Moriggi, Michele Vasso, Pio D’Adamo, Flavia Blàsevich, Simona Zanotti, Cecilia Paolini, Feliciano Protasi et al. · 2015 · Journal of Medical Genetics
  56. Emerging Implications of Genetic Testing in Inherited Primary Arrhythmia Syndromes
    B. Asatryan, A. Medeiros-Domingo · 2019 · Cardiology in Review
  57. Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes
    Daniel J. Clemens, Dan Ye, Lili Wang, C.S. John Kim, Wei Zhou, Steven Michael Dotzler, David J. Tester, Isabelle Marty, Björn C. Knollmann, Michael John Ackerman · 2023 · Stem Cell Reports
  58. CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
    Qirui Li, Ruolan Guo, Lu Gao, Lang Cui, Zhihui Zhao, Xia Yu, Yue Yuan, Xiwei Xu · 2019 · Molecular Genetics & Genomic Medicine
  59. Long-Term Follow-Up of Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
    Michael Veith, Ibrahim El‐Battrawy, Gretje Roterberg, Laura S. Raschwitz, Siegfried Lang, Christian Wolpert, Rainer Schimpf, Xiaobo Zhou, İbrahim Akın, Martin M. Borggrefe · 2020 · Journal of Clinical Medicine
  60. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia
    Junko Arakawa, Akira Hamabe, Takeshi Aiba, Tomoo Nagai, Mikoto Yoshida, Takumi Toya, Norio Ishigami, Hideki Hisadome, Shuichi Katsushika, Hirotsugu Tabata et al. · 2014 · Heart and Vessels
  61. Potential adverse interaction of human cardiac calsequestrin
    ChulHee Kang, Mark S. Nissen, Emiliano J. Sanchez, Ka-Sum Lam, Hendrik Milting · 2010 · European Journal of Pharmacology
  62. Genetics of ventricular tachycardia
    Carlo Napolitano, Silvia Giuliana Priori · 2002 · Current Opinion in Cardiology
  63. Genetic causes of sudden cardiac death in the young
    Andrea Mazzanti, Riccardo Maragna, Silvia Giuliana Priori · 2017 · Current Opinion in Cardiology
  64. Advances in the Molecular Genetics of Catecholaminergic Polymorphic Ventricular Tachycardia
    Junxia Song, Yanhong Luo, Ying Jiang, Jianfeng He · 2021 · Frontiers in Pharmacology
  65. The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2)
    Guy Katz, Asher Shainberg, Edith Hochhauser, Efrat Kurtzwald-Josefson, Ahuva Isaac, Dalia El‐Ani, Dan J. Aravot, Arnon B. Afek, Jonathan G. Seidman, Christine E. Seidman et al. · 2013 · Biochemical Pharmacology
  66. Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases
    Gaetano Vacanti, Riccardo Maragna, Silvia Giuliana Priori, Andrea Mazzanti · 2017 · Current Opinion in Pediatrics
  67. Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype
    Daniel J. Flores, ThuyVy Duong, Luke O. Brandenberger, Apratim Mitra, Aditya Shirali, John C Johnson, Danielle Springer, Audrey C. Noguchi, Zu‐Xi Yu, Steven N. Ebert et al. · 2018 · Human Molecular Genetics
  68. Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia
    Wen‐Chin Tsai, Yen‐Yu Lu, Yao‐Chang Chen, CHIEN‐JUNG CHANG, Yu‐Hsun Kao, Yung‐Kuo Lin, Yu-Hsin Chen, Shih‐Ann Chen, Liang‐Yo Yang, Yi‐Jen Chen · 2015 · International Journal of Cardiology
  69. Catecholaminergic Polymorphic Ventricular Tachycardia and Short-coupled Torsades de Pointes
    Carlo Napolitano, Silvia Giuliana Priori · 2004 · Elsevier eBooks
  70. Calmodulinopathy in Japanese Children ― Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy ―
    Megumi Fukuyama, Minoru Horie, Koichi Kato, Hisaaki Aoki, Shuhei Fujita, Yoko Yoshida, Hisanori Sakazaki, Takako Toda, Michihiko Ueno, Gaku Izumi et al. · 2023 · Circulation Journal
  71. Distinct mechanisms mediate pacemaker dysfunction associated with catecholaminergic polymorphic ventricular tachycardia mutations: Insights from computational modeling
    Limor Arbel-Ganon, Joachim A. Behar, Ana Maria Gomez, Yael Yaniv · 2020 · Journal of Molecular and Cellular Cardiology
  72. Catecholaminergic Polymorphic Ventricular Tachycardia and Gene Therapy: A Comprehensive Review of the Literature
    Elvis Henriquez, Edwin A Hernandez, Sravya R Mundla, Diptish Wankhade, Muhammad Saad, Sagar S Ketha, Yasaswini Penke, Gabriela C Martinez, Faiza S Ahmed, Muhammad Sheheryar Hussain · 2023 · Cureus
  73. Flecainide and Antiarrhythmic Effects in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
    Nian Liu, Carlo Napolitano, Luigi A. Venetucci, Silvia Giuliana Priori · 2012 · Trends in Cardiovascular Medicine
  74. Impaired calcium-calmodulin-dependent inactivation of Cav1.2 contributes to loss of sarcoplasmic reticulum calcium release refractoriness in mice lacking calsequestrin 2
    Dmytro O. Kryshtal, Oleksiy Gryshchenko, Nieves Gómez‐Hurtado, Björn C. Knollmann · 2015 · Journal of Molecular and Cellular Cardiology
  75. The investigation of sudden arrhythmic death syndrome (SADS)—the current approach to family screening and the future role of genomics and stem cell technology
    Vishal S. Vyas, Pier David Lambiase · 2013 · Frontiers in Physiology
  76. A Clinical Approach to a Family History of Sudden Death
    B. Tan, D. Judge · 2012 · Circulation: Cardiovascular Genetics
  77. Catecholaminergic Polymorphic Ventricular Tachycardia
    Marwan M. Refaat, Sylvana Hassanieh, Melvin M. Scheinman · 2016 · Cardiac Electrophysiology Clinics
  78. Accelerated Junctional Rhythm and Nonalternans Repolarization Lability Precede Ventricular Tachycardia in Casq2−/− Mice
    Ure L. Mezu, Prabhpreet Singh, Vladimir Shusterman, HYUN‐SEOK HWANG, Björn C. Knollmann, Jan Němec · 2012 · Journal of Cardiovascular Electrophysiology
  79. Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
    Wenbin Liang, Lilit Gasparyan, Wael Alqarawi, Darryl Raymond Davis · 2019 · Expert Opinion on Biological Therapy
  80. Exercise-Induced Ventricular Arrhythmias in Patients with No Structural Cardiac Disease
    Melvin M. Scheinman, Jason T. Lam · 2006 · Annual Review of Medicine
  81. Would modulation of intracellular Ca2+ be antiarrhythmic?
    Penelope A. Boyden, Henk E.D.J. ter Keurs · 2005 · Pharmacology & Therapeutics
  82. Identifying Features of Cardiac Disease Phenotypes Based on Mechanical Function in a Catecholaminergic Polymorphic Ventricular Tachycardia Model
    Alana Stempien, Mitchell B. Josvai, Willem J. de Lange, Jonathan J. Hernández, Jacob Notbohm, Timothy J. Kamp, Héctor H. Valdivia, Lee L. Eckhardt, Kathleen R. Maginot, J. Carter Ralphe et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  83. Catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2 mutation: recreational cycling as a trigger of lethal arrhythmias
    Antonio Cortez, Néstor Ortiz, Erika Argüellez, Teresa Molina, Armando Serra, Pedro Iturralde Torres, Manlio Fabio Márquez · 2019 · Archives of Medical Science
  84. iPCS Cell Modeling of Inherited Cardiac Arrhythmias
    Rami Shinnawi, Lior Gepstein · 2014 · Current Treatment Options in Cardiovascular Medicine
  85. Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia
    Thomas M. Roston, Taylor C. Cunningham, Shubhayan Sanatani · 2017 · Cardiology in the Young
  86. Bidirectional ventricular tachycardia and channelopathy
    Preecha Laohakunakorn, D. Woodrow Benson, Ping Yang, Tao Yang, Dan M. Roden, John D. Kugler · 2003 · The American Journal of Cardiology
  87. A genetic and developmental biological approach for a family with complex congenital heart diseases—evidence of digenic inheritance
    Yu Yoshida, Keiko Uchida, Kazuki Kodo, Reina Ishizaki, Jun Maeda, Yoshinori Katsumata, Shinsuke Yuasa, Keiichi Fukuda, Kenjiro Kosaki, Yusuke Watanabe et al. · 2023 · Frontiers in Cardiovascular Medicine
  88. Genetic Basis of Malignant Channelopathies and Ventricular Fibrillation in the Structurally Normal Heart
    Nynke Hofman, Laura T. van Lochem, Arthur A.M. Wilde · 2010 · Future Cardiology
  89. A rare cause of sudden cardiac arrest: Catecholaminergic polymorphic ventricular tachycardia
    Sezen Ugan Atik, Firuze Erbek Alp, Reyhan Dedeoğlu, Aida Koka, Funda Öztunç, Ayşe Güler Eroğlu · 2018 · Türk Pediatri Arşivi
  90. The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies
    Merima Begovic, Luca Schneider, Xiaobo Zhou, Nazha Hamdani, İbrahim Akın, Ibrahim El‐Battrawy · 2024 · International Journal of Molecular Sciences
  91. Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function
    Arne A.N. Bruyneel, Wesley L. McKeithan, Dries A. M. Feyen, Mark A. Mercola · 2018 · Current Cardiology Reports
  92. Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia
    Paloma Remior Pérez, Robyn J. Hylind, Thomas M. Roston, Vassilios J. Bezzerides, Dominic James Abrams · 2023 · Heart Lung and Circulation
  93. The Phenotype of a CASQ2 Mutation in a Saudi Family with Catecholaminergic Polymorphic Ventricular Tachycardia
    Zuhair N. Al‐Hassnan, Sahar Tulbah, Waleed Al-Manea, Majid Al-Fayyadh · 2012 · Pacing and Clinical Electrophysiology
  94. Regulation of RYR2 by sarcoplasmic reticulum Ca2+
    Joe Z. Zhang, Helen M. M. Waddell, Peter P. Jones · 2015 · Clinical and Experimental Pharmacology and Physiology
  95. The Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia*
    Nicola Monteforte, Silvia Giuliana Priori · 2009 · Pacing and Clinical Electrophysiology
  96. Array comparative genomic hybridization identifies a heterozygous deletion of exon 3 of theRYR2gene
    Ivone Un San Leong, Jennifer Sucich, Debra O. Prosser, Jonathan Robert Skinner, Jackie Crawford, Colleen M. Higgins, Donald R. Love · 2015 · Upsala Journal of Medical Sciences
  97. Arrhythmias in Athletes
    Nikolaos Fragakis, Efstathios D. Pagourelias, Konstantinos C. Koskinas, Vassilios Pericles Vassilikos · 2013 · Cardiology in Review
  98. Catecholaminergic Polymorphic Ventricular Tachycardia
    Jessica J. Wall, Ramesh V. Iyer · 2017 · Pediatric Emergency Care
  99. An antidote for calcium leak: Targeting molecular arrhythmia mechanisms
    Stephan E. Lehnart, W. JON LEDERER · 2009 · Journal of Molecular and Cellular Cardiology
  100. Ryanodine Receptor Dysfunction in Arrhythmia and Sudden Cardiac Death
    Christopher H George, Nia Lowri Thomas, Francis Anthony Lai · 2005 · Future Cardiology